Results of the prematurely terminated TEMPLE randomized controlled trial in patients with myelodysplastic syndrome: liberal versus restrictive red blood cell transfusion threshold
- 1 April 2020
- journal article
- letter
- Published by Wiley in Transfusion
- Vol. 60 (4), 879-881
- https://doi.org/10.1111/trf.15708
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Low vs high hemoglobin trigger for transfusion in vascular surgery: a randomized clinical feasibility trialBlood, 2019
- Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell supportEmergencias, 2017
- Transfusion policy after severe postpartum haemorrhage: a randomised non‐inferiority trialBJOG: An International Journal of Obstetrics and Gynaecology, 2014
- Quality of life measurement in patients with transfusion‐dependent myelodysplastic syndromesBritish Journal of Haematology, 2003
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982